SCHEMBL19974148

SCHEMBL19974148

Cc1cnc(NC(=O)C=CC(=O)O)s1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 11/20 0.59
NPC1 O15118 10/20 0.59
SMN1; SMN2 Q16637 8/20 0.59
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
MAPT P10636 3/20 0.59
HTT P42858 2/20 0.59
KDM4E B2RXH2 1/20 0.59
ALDH1A1 P00352 1/20 0.59
BLM P54132 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
POLB P06746 2/20 0.56
TP53 P04637 1/20 0.49
PKM P14618 4/20 0.49
LMNA P02545 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19974146 1.00 RAB9A (0.59) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL23647324 0.81 MAPT (0.64) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL3794688 0.81 RAB9A (0.62) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL31321054 0.80 GSTO1 (0.57) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL19974282 0.77 MAPT (0.40) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL19974283 0.77 MAPT (0.40) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL19974176 0.77 ALDH1A1 (0.51) RAB9ANPC1MEN1KMT2AMAPT
SCHEMBL19974175 0.77 ALDH1A1 (0.51) RAB9ANPC1MEN1KMT2AMAPT
SCHEMBL3040422 0.76 RAB9A (0.57) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL19974173 0.76 GSTO1 (0.72) MEN1KMT2AMAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512602-B1 INHIBITORS OF HEAT SHOCK FACTORS (HSF) AND USES THEREOF HSF PHARMACEUTICALS (CH) 2024-03-27 EP disclosed
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2023-03-07 US disclosed
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2021-07-22 US disclosed
EP-3512602-A2 INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF HSF Pharmaceuticals (CH) 2019-07-24 EP disclosed
WO-2018050656-A2 INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF HSF PHARMACEUTICALS (CH) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 RAB9A 4035/4885NPC1 3462/4885SMN1; SMN2 4284/4885
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 RAB9A 4035/4885NPC1 3462/4885SMN1; SMN2 4284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.